Royalty Pharma Ownership | Who Owns Royalty Pharma?

Overview Forecast RevenueFinancials Chart Transcripts

Royalty Pharma Ownership Summary

Royalty Pharma is owned by 62.44% institutional investors, 8.82% insiders, and 28.74% retail investors. Morgan stanley is the largest institutional shareholder, holding 12.86% of RPRX shares. Vanguard US Total Market Shares ETF is the top mutual fund, with 2.77% of its assets in Royalty Pharma shares.

RPRX Ownership Benchmark

Type	Name	% Inst	% Insiders	% Retail
Stock	Royalty Pharma	62.44%	8.82%	28.74%
Sector	Healthcare Stocks	232.51%	10.72%	-143.23%
Industry	Biotech Stocks	384.56%	10.58%	-295.14%

Institutional Shareholders

Top Institutional Shareholders by Total Shares

Holder	Shares	% Holding	Value
Morgan stanley	55.27M	12.86%	$2.14B
Capital investors	31.10M	7.24%	$1.20B
Fmr	27.99M	6.47%	$987.37M
Blackrock funding, inc. /de	26.19M	6.09%	$1.01B
Blackrock	23.02M	5.13%	$606.97M
Baillie gifford	17.01M	3.94%	$657.22M
Adage capital partners gp	11.97M	2.77%	$422.15M
Swedbank ab	11.94M	2.77%	$461.44M
State street	10.27M	2.38%	$362.42M
Vanguard group	9.93M	2.30%	$383.87M

Top Institutional Shareholders by % of Total Assets

Holder	Shares	% Assets	Value
Dorsey asset management	2.35M	7.45%	$82.92M
New south capital management	2.93M	5.21%	$113.17M
Cooper investors pty	386.44K	4.96%	$14.93M
Cutter capital management, lp	356.89K	4.84%	$11.11M
Patient capital management	3.12M	4.40%	$110.00M
Caledonia (private) investments pty	7.55M	4.33%	$266.28M
Lion point capital, lp	21.40K	4.29%	$754.99K
Torray investment partners	744.36K	4.12%	$28.76M
Pacific capital partners	94.75K	3.89%	$3.66M
Regal partners	1.44M	3.62%	$50.63B

Top Buyers

Holder	Shares	% Assets	Change
Morgan stanley	55.27M	0.13%	11.11M
Adage capital partners gp	11.97M	0.67%	5.97M
Capital investors	31.10M	0.19%	3.89M
Norges bank	3.41M	0.01%	3.41M
Dorsey asset management	2.35M	7.45%	2.35M

Top Sellers

Holder	Shares	% Assets	Change
Fmr	27.99M	0.05%	-12.37M
Unisphere establishment	-	-	-5.00M
Viking global investors lp	-	-	-2.60M
Jupiter asset management	-	-	-2.47M
Gmt capital	-	-	-2.38M

New Positions

Holder	Shares	% Assets	Change	Value
Norges bank	3.41M	0.01%	3.41M	$131.92M
Dorsey asset management	2.35M	7.45%	2.35M	$82.92M
Clark capital management group	1.75M	0.39%	1.75M	$61.80M
Marshall wace, llp	1.48M	0.05%	1.48M	$52.34M
Weiss asset management lp	457.47K	0.20%	457.47K	$16.14M

Sold Out

Holder	Change
Financial gravity asset management	-2.00
Harbor investment advisory	-4.00
Palisade asset management	-6.00
Mather group, llc.	-8.00
Strengthening families & communities	-8.00

Institutional Ownership Trends

Date	Holdings	Change %	Shares	Change %	Ownership	Change %	Increased Position	Change %	Decreased Position	Change %
Dec 31, 2025	409	-17.71%	269,689,122	-17.74%	62	1.09%	253	-14.53%	102	-24.44%
Sep 30, 2025	482	3.43%	326,746,376	-4.38%	75	1.16%	287	15.26%	130	-16.13%
Jun 30, 2025	456	-1.30%	341,289,005	7.83%	80	1.51%	248	-	148	2.07%
Mar 31, 2025	3	-99.28%	2,405,220	-99.25%	-	0.01%	1	-99.58%	2	-98.51%
Dec 31, 2024	382	-3.78%	305,326,416	-0.72%	68	1.45%	210	-2.78%	129	6.61%

Top Mutual Funds Shareholders

Holder	Shares	% Holding	Change
Vanguard US Total Market Shares ETF	12.01M	2.77%	-167.60K
Vanguard Total Stock Mkt Idx Inv	11.25M	2.60%	-258.49K
Vanguard Mid Cap Index Institutional	7.99M	1.85%	86.30K
Capital Group New Perspective Comp	7.08M	1.68%	7.08M
American Funds New Perspective A	7.08M	1.68%	7.08M
Morgan Stanley Inst Growth I	5.94M	1.38%	580.21K
Morgan Stanley Growth	5.94M	1.38%	261.46K
Morgan Stanley Growth SMA	5.94M	1.38%	261.46K
MS INVF US Advantage I	5.41M	1.25%	-
MS INVF US Growth I	4.59M	1.06%	-45.55K

Recent Insider Transactions

Date	Name	Role	Activity	Value
Feb 04, 2026	Coyne Terrance P.	EVP & CFO	Sell	$825.85K
Feb 02, 2026	Coyne Terrance P.	EVP & CFO	Sell	$245.90K
Feb 02, 2026	Coyne Terrance P.	EVP & CFO	Sell	$4.32M
Feb 03, 2026	Coyne Terrance P.	EVP & CFO	Sell	$4.66M
Feb 03, 2026	Coyne Terrance P.	EVP & CFO	Sell	$265.41K

Insider Transactions Trends

Date	Buy	Sell
2026 Q1	-	15
2025 Q4	-	28
2025 Q3	-	1
2025 Q2	-	-
2025 Q1	-	-

RPRX Ownership FAQ

Who Owns Royalty Pharma?

Royalty Pharma shareholders are primarily institutional investors at 62.44%, followed by 8.82% insiders and 28.74% retail investors. The average institutional ownership in Royalty Pharma's industry, Biotech Stocks , is 384.56%, which Royalty Pharma falls below.

Who owns the most shares of Royalty Pharma?

Royalty Pharma’s largest shareholders are Morgan stanley (55.27M shares, 12.86%), Capital investors (31.1M shares, 7.24%), and Fmr (27.99M shares, 6.47%). Together, they hold 26.57% of Royalty Pharma’s total shares outstanding.

Does Blackrock own Royalty Pharma?

Yes, BlackRock owns 5.13% of Royalty Pharma, totaling 23.02M shares as of Jun 2024. This represents 0.01% of BlackRock's total assets, with a market value of 606.97M$. In the last quarter, BlackRock increased its holdings by 1.81M shares, a 8.54% change.

Who is Royalty Pharma’s biggest shareholder by percentage of total assets invested?

Dorsey asset management is Royalty Pharma’s biggest shareholder by percentage of total assets invested, with 7.45% of its assets in 2.35M Royalty Pharma shares, valued at 82.92M$.

Who is the top mutual fund holder of Royalty Pharma shares?

Vanguard US Total Market Shares ETF is the top mutual fund holder of Royalty Pharma shares, with 2.77% of its total shares outstanding invested in 12.01M Royalty Pharma shares.

Try Tickergate Pro Free

Customize Everything. 100% Flexibility. Fast and Easy to Use (No code or Excel Needed)

Customize your own personal stocks lists, views and charts
Choose from hundreds of fields, up to 15 years of history
Conduct deep comparison analysis

Discover trending investment themes
Find your next best investment
Research stocks using tools